REPORT ID 2742

EMEA (Europe, Middle East and Africa) Diphtheria Vaccine Market Report 2017

Publish Date
11-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Diphtheria Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Diphtheria Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Diphtheria Vaccine market competition by top manufacturers/players, with Diphtheria Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Sanofi Pasteur
    Wyeth (Pfizer)
    Merck
    Novartis
    Beijing Tiantan Biological Products
    Shanghai Institute of Biological Products
    Wuhan Institute of Biological Products
    Chengdu Institute of Biological Products
    Changchun Changsheng Life Sciences

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    DTaP
    DT
    Td
    Tdap

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    For infants and children younger than seven years of age
    For adolescents and adults

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Diphtheria Vaccine Market Report 2017
1 Diphtheria Vaccine Overview
    1.1 Product Overview and Scope of Diphtheria Vaccine
    1.2 Classification of Diphtheria Vaccine
        1.2.1 EMEA Diphtheria Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Diphtheria Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 DTaP
        1.2.4 DT
        1.2.5 Td
        1.2.6 Tdap
    1.3 EMEA Diphtheria Vaccine Market by Application/End Users
        1.3.1 EMEA Diphtheria Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 For infants and children younger than seven years of age
        1.3.3 For adolescents and adults
    1.4 EMEA Diphtheria Vaccine Market by Region
        1.4.1 EMEA Diphtheria Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Diphtheria Vaccine (2012-2022)
        1.5.1 EMEA Diphtheria Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Diphtheria Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Diphtheria Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Diphtheria Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Diphtheria Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Diphtheria Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Diphtheria Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Diphtheria Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Diphtheria Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Diphtheria Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Diphtheria Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Diphtheria Vaccine (Volume) by Application
    2.4 EMEA Diphtheria Vaccine (Volume and Value) by Region
        2.4.1 EMEA Diphtheria Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Diphtheria Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Diphtheria Vaccine Sales Price by Region (2012-2017)

3 Europe Diphtheria Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Diphtheria Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Diphtheria Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Diphtheria Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Diphtheria Vaccine Sales and Market Share by Type
    3.3 Europe Diphtheria Vaccine Sales and Market Share by Application
    3.4 Europe Diphtheria Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Diphtheria Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Diphtheria Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Diphtheria Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Diphtheria Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Diphtheria Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Diphtheria Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Diphtheria Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Diphtheria Vaccine Sales and Market Share by Type
    4.3 Middle East Diphtheria Vaccine Sales and Market Share by Application
    4.4 Middle East Diphtheria Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Diphtheria Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Diphtheria Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Diphtheria Vaccine Sales and Growth Rate (2012-2017)

5 Africa Diphtheria Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Diphtheria Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Diphtheria Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Diphtheria Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Diphtheria Vaccine Sales and Market Share by Type
    5.3 Africa Diphtheria Vaccine Sales and Market Share by Application
    5.4 Africa Diphtheria Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Diphtheria Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Diphtheria Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Diphtheria Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Diphtheria Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Diphtheria Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Diphtheria Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi Pasteur
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Diphtheria Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Pasteur Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Wyeth (Pfizer)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Diphtheria Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Wyeth (Pfizer) Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Diphtheria Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Novartis
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Diphtheria Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Novartis Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Beijing Tiantan Biological Products
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Diphtheria Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Beijing Tiantan Biological Products Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Shanghai Institute of Biological Products
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Diphtheria Vaccine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Shanghai Institute of Biological Products Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Wuhan Institute of Biological Products
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Diphtheria Vaccine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Wuhan Institute of Biological Products Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Chengdu Institute of Biological Products
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Diphtheria Vaccine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Chengdu Institute of Biological Products Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Changchun Changsheng Life Sciences
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Diphtheria Vaccine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Changchun Changsheng Life Sciences Diphtheria Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Diphtheria Vaccine Manufacturing Cost Analysis
    7.1 Diphtheria Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Diphtheria Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Diphtheria Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Diphtheria Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Diphtheria Vaccine Market Forecast (2017-2022)
    11.1 EMEA Diphtheria Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Diphtheria Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Diphtheria Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Diphtheria Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Diphtheria Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Diphtheria Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Diphtheria Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Diphtheria Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Diphtheria Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Diphtheria Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer